ClassID:

20213

A61K31/121 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Ketones acyclic

Recent Application in this class:
#1
20260130875
2026-05-14

S-BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES

#2
20260130864
2026-05-14

METHOD AND COMPOSITION FOR ENHANCING EXERCISE PERFORMANCE

#3
20260124146
2026-05-07

MODIFIED RELEASE TOLCAPONE FORMULATIONS

#4
20260116838
2026-04-30

NEOCARZILIN DERIVATIVES AS ANTIMETASTATIC AGENTS

#5
20260115249
2026-04-30

NEURAL REPAIR COMPOSITION, METHOD OF PREPARATION, AND USE THEREOF

#6
20260115152
2026-04-30

AGRIMOL B DERIVATIVES AND METHODS OF MAKING AND USE THEREOF

#7
20260090982
2026-04-02

TRANSDERMAL DELIVERY FORMULATIONS

#8
20260069652
2026-03-12

LIVER HEALTH SUPPLEMENT FOR COMPANION ANIMALS

#9
20260053755
2026-02-26

PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA

#10
20260048173
2026-02-19

ECO-SKIN: A Kombucha SCOBY-Derived Cellulose Matrix for Accelerated Healing and Antimicrobial Defense

#11
20260048095
2026-02-19

Treatment of Neuroinflammation

#12
20260048062
2026-02-19

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF PSYCHOSIS AND PSYCHOTIC DISORDERS

#13
20260041664
2026-02-12

COMPOSITION AND USE THEREOF

#14
20260034057
2026-02-05

ORODISPERSIBLE TABLET, IN PARTICULAR FOR USE AS A FOOD SUPPLEMENT

#15
20260033489
2026-02-05

NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS

#16
20250367138
2025-12-04

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND METHYLGLYOXAL

#17
20250367098
2025-12-04

SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN

#18
20250352615
2025-11-20

COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4

#19
20250302854
2025-10-02

ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS

#20
20250281560
2025-09-11

METHOD FOR PREVENTING AND/OR TREATING CANCER OR AUTOIMMUNE DISEASE WITH 3,4,2 Prime,3 Prime,4 Prime-PENTAHYDROXY-TRANS-CHALCONE

#21
20250281488
2025-09-11

VCP INHIBITORS AND USES THEREOF FOR TREATMENT

#22
20250275986
2025-09-04

COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT

#23
20250268852
2025-08-28

MICROBIOTA IMPROVING AGENT

#24
20250212873
2025-07-03

VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS

#25
20250177292
2025-06-05

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

#26
20250134918
2025-05-01

COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR

#27
20250114359
2025-04-10

METHODS FOR INHIBITING PARASITIC GLUCOKINASE AND/OR HEXOKINASE

#28
20250064721
2025-02-27

TRANSDERMAL DELIVERY FORMULATIONS

#29
20250025434
2025-01-23

S-BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES

#30
20250009691
2025-01-09

DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER

#31
20240390264
2024-11-28

TRANSDERMAL DELIVERY FORMULATIONS

#32
20240366586
2024-11-07

METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE

#33
20240358710
2024-10-31

METHODS, COMPOSITIONS AND DEVICES FOR TREATING CANCER WITH ILLUDOFULVENES

#34
20240342203
2024-10-17

COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER

#35
20240335456
2024-10-10

CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE

#36
20240238220
2024-07-18

METHODS FOR TREATING CANCERS

#37
20240226185
2024-07-11

MIXTURE FOR TREATMENT OF RESPIRATORY ILLNESSES

#38
20240216411
2024-07-04

METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS

#39
20240207408
2024-06-27

Solid Solution Compositions and Use in Severe Pain

#40
20240156720
2024-05-16

Compositions for blood storage and transfusions

#41
20240122890
2024-04-18

USE OF EXOGENOUS KETONE ESTERS TO INDUCE WEIGHT LOSS IN MAMMALS

#42
20240082281
2024-03-14

ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS

#43
20240058292
2024-02-22

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, AND PREPARATION METHOD AND USE THEREOF

#44
20240050362
2024-02-15

Transdermal delivery formulations

#45
20240041967
2024-02-08

COMPOSITIONS AND METHODS RELATED TO RHAMNUS PRINOIDES (GESHO) EXTRACT FOR THE INHIBITION OF POLYMICROBIAL BIOFILM FORMATION

#46
20240041799
2024-02-08

Agmatine compositions for treatment of osteoarthritis

#47
20240041027
2024-02-08

NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS

#48
20240033214
2024-02-01

TRANSDERMAL DELIVERY FORMULATIONS

#49
20240024265
2024-01-25

COMPOSITIONS AND METHODS FOR KETO STACKING WITH BETA-HYDROXYBUTYRATE AND ACETOACETATE

#50
20230346721
2023-11-02

BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES

#51
20230321122
2023-10-12

ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN HAIR GROWTH REGULATION

#52
20230293763
2023-09-21

Antimicrobial Diapering Device

#53
20230263723
2023-08-24

Transdermal delivery formulations

#54
20230201145
2023-06-29

BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR ORAL DELIVERY OF KETONE BODIES

#55
20230190839
2023-06-22

COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS

#56
20230190774
2023-06-22

METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS

#57
20230173004
2023-06-08

Method and Composition for Treating Ringworm on Biotic and Abiotic Surfaces

#58
20230172860
2023-06-08

A NOVEL METHOD FOR CARRYING BIOACTIVE MOLECULES USING NANOCARRIERS

#59
20230165834
2023-06-01

ALPHA LIPOIC ACID, EPIGALLOCATECHIN 3-GALLATE, AND CURCUMIN AS A MEDICAMENT FOR THE TREATMENT OF ARTHRITIS AND SARS-COV-2

#60
20230165807
2023-06-01

COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF

#61
20230147612
2023-05-11

NUTRITIONAL HEALTH SUPPLEMENTS

#62
20230121214
2023-04-20

TRANSDERMAL DELIVERY FORMULATIONS

#63
20230118955
2023-04-20

VIRAL TREATMENTS INVOLVING MANUKA HONEY AND COMPONENTS THEREOF

#64
20230111140
2023-04-13

TREATMENT OF PAIN BY TARGETING NR4A1

#65
20230100108
2023-03-30

PLANT BASED SUPPLEMENT COMPOSITIONS

#66
20230094051
2023-03-30

DIMETHYLTRIPTAMINE-BASED NASAL SPRAY FOR THE PERSONALISED TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

#67
20230084246
2023-03-16

COMPOSITION CONTAINING CURCUMIN COMPOUND, AND METHOD FOR PRODUCING SAME

#68
20230049572
2023-02-16

FORMULATION, COMPOSITION OR FOODSTUFF ADDITIVES FOR THE MODIFICATION OF GLYCEMIC RESPONSE METHODS OF MANUFACTURING AND USING THE SAME

#69
20230047847
2023-02-16

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

#70
20230045616
2023-02-09

CANCER TREATMENT METHOD AND MEDICINE

#71
20230000940
2023-01-05

Composition for prevention or treatment of Porcine epidemic diarrhea virus infection comprising curcuminoid and licorice extracts or fraction thereof

#72
20220401384
2022-12-22

Synthetic antibacterial compounds and uses thereof

#73
20220362341
2022-11-17

TREATMENT OF MAJOR DEPRESSIVE DISORDER BY LOW DOSE INTERLEUKIN-2

#74
20220362260
2022-11-17

METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET

#75
20220304958
2022-09-29

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

#76
20220265576
2022-08-25

PHOSPHOLIPASE-A2 INHIBITORS FOR THE PREVENTION OF CANCER METASTASIS

#77
20220257531
2022-08-18

COMPOSITIONS AND METHODS FOR TREATMENT OF A FIBROTIC DISEASE

#78
20220226345
2022-07-21

CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE

#79
20220226261
2022-07-21

Dihydrochalcone derivatives influencing inflammatory states

#80
20220202713
2022-06-30

Curcumin Solubilisate

#81
20220193177
2022-06-23

METHODS AND COMPOSITIONS FOR TREATING DYSBIOSIS OF ORAL MICROBIOME

#82
20220143198
2022-05-12

COMPOSITIONS AND METHODS RELATED TO TETHERED KETHOXAL DERIVATIVES

#83
20220143053
2022-05-12

ANTI-MICROBIAL METHODS AND MATERIALS

#84
20220142947
2022-05-12

Transdermal delivery formulations

#85
20220142913
2022-05-12

TRANSDERMAL DELIVERY FORMULATIONS

#86
20220118091
2022-04-21

Solid solution compositions and use in severe pain

#87
20220096637
2022-03-31

Solid solution compositions comprising cannabidiols

#88
20220040191
2022-02-10

Methods, compositions and devices for treating cancer with illudofulvenes

#89
20220031719
2022-02-03

ANTIVIRAL THERAPEUTIC DRUG COMBINATIONS

#90
20210401793
2021-12-30

Treatment of cutaneous disorders

#91
20210393674
2021-12-23

OZONOLYSIS FOR ACTIVATION OF COMPOUNDS AND DEGRADATION OF OZONE

#92
20210290647
2021-09-23

Compositions for oral cancer or an oropharyngeal cancer

#93
20210267251
2021-09-02

COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR

#94
20210260087
2021-08-26

GLYCOALKALOID COMBINATIONS AND VARIOUS USES THEREOF

#95
20210228514
2021-07-29

Solid solution compositions and use in chronic inflammation

#96
20210205241
2021-07-08

Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies

#97
20210186998
2021-06-24

COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS

#98
20210137862
2021-05-13

Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate

#99
20210128662
2021-05-06

Compositions and methods related to (GESHO) extract for the inhibition of polymicrobial biofilm formation

#100
20210128498
2021-05-06

Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide

#101
20210121488
2021-04-29

COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR

#102
20210093560
2021-04-01

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

#103
20210077370
2021-03-18

Use of compositions comprising dihydroxyacetone for the protection of skin or hair against infrared irradiation

#104
20210015757
2021-01-21

DRUG DELIVERY BY PORE-MODIFIED MESOPOROUS SILICA NANOPARTICLES

#105
20200377441
2020-12-03

METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE

#106
20200352991
2020-11-12

POLYMER FILMS WITH ANTIMICROBIAL AGENTS

#107
20200330399
2020-10-22

COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A CORTICOSTEROID

#108
20200316205
2020-10-08

Solid solution compositions and use in severe pain

#109
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#110
20200297850
2020-09-24

Solid solution compositions and use in cardiovascular disease

#111
20200289453
2020-09-17

Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders

#112
20200261378
2020-08-20

Pharmaceutical composition

#113
20200206246
2020-07-02

Composition and uses thereof

#114
20200206170
2020-07-02

Solid solution compositions and use in chronic inflammation

#115
20200179307
2020-06-11

HISTONE DEACETYLASE INHIBITORS

#116
20200155498
2020-05-21

Treatment of cutaneous disorders

#117
20200129461
2020-04-30

Compositions Comprising Cancer Drug-Fatty Acid Conjugates

#118
20200121617
2020-04-23

Treatment of vulvar pain

#119
20200108050
2020-04-09

Methods for treating diseases

#120
20200085909
2020-03-19

Buckwheat honey and bacitracin wound-healing dressing

#121
20200061076
2020-02-27

METHODS OF TREATING LEUKODYSTROPHIES

#122
20200054687
2020-02-20

Wound healing compositions and methods of use

#123
20200046652
2020-02-13

TREATMENT FOR GLIOBLASTOMA

#124
20200038342
2020-02-06

FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY

#125
20200016184
2020-01-16

Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses

#126
20200000744
2020-01-02

PHARMACEUTICAL COMPOSITION

#127
20190374645
2019-12-12

Absorption promoter and use for same

#128
20190343856
2019-11-14

Compositions for the treatment of skin conditions

#129
20190321309
2019-10-24

Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate

#130
20190255138
2019-08-22

A NATURAL COMPOSITION TO INHIBIT BETA-SECRETASE AND ENHANCE BIOAVAILABILITY COMPRISING OF TURMERIC AND SESAME SEED EXTRACT

#131
20190240271
2019-08-08

Compositions for atopic skin

#132
20190218165
2019-07-18

Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases

#133
20190216815
2019-07-18

COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A FOLIC ACID PARTNER

#134
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#135
20190167606
2019-06-06

Dermatitis treatment

#136
20190167578
2019-06-06

Transmucosal Delivery of Terpenes Via Edible Film

#137
20190167549
2019-06-06

Preservation booster

#138
20190160147
2019-05-30

Treatment of heart failure with preserved ejection fraction

#139
20190133126
2019-05-09

Coatings and methods for infection-resistant medical devices

#140
20190091247
2019-03-28

Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs

#141
20190091185
2019-03-28

Solid solution compositions and use in chronic inflammation

#142
20190083624
2019-03-21

Solid solution compositions and use in severe pain

#143
20190083623
2019-03-21

Solid solution compositions and use in cardiovascular disease

#144
20190076423
2019-03-14

Combination therapy for proliferative diseases

#145
20190070137
2019-03-07

Solid solution compositions and use in chronic inflammation

#146
20190064161
2019-02-28

OLFR90 specificity and methods of detection

#147
20190060271
2019-02-28

Crosslinker enhanced repair of connective tissues

#148
20190008913
2019-01-10

Topical Treatment Compositions Comprising Benzoin and Olive Fruit Extract

#149
20190008811
2019-01-10

Solid solution compositions and use in chronic inflammation

#150
20190000785
2019-01-03

Solid solution compositions and use in chronic inflammation

#151
20190000777
2019-01-03

Use of dihydroxyacetone in preparation of anti-cancer medicaments

#152
20180360775
2018-12-20

Histone deacetylase inhibitors

#153
20180338939
2018-11-29

Methods of quantifying N-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG

#154
20180265442
2018-09-20

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#155
20180235928
2018-08-23

Compositions and methods for selectively inhibiting intestinal carboxylesterase 2 enzyme activity

#156
20180207110
2018-07-26

COMPOSITION AND METHOD FOR INHIBITION OF NERVE TRANSMISSION

#157
20180193287
2018-07-12

HOPS-BASED SUBSTANCE AND USE OF THE SUBSTANCE

#158
20180153825
2018-06-07

HONEY FORTIFIED WITH DIHYDROXYACETONE AND METHODS OF MAKING SAME

#159
20180050003
2018-02-22

Solid solution compositions and use in chronic inflammation

#160
20180050002
2018-02-22

Solid solution compositions and use in chronic inflammation

#161
20180042877
2018-02-15

Solid solution compositions and use in chronic inflammation

#162
20180037529
2018-02-08

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#163
20180036258
2018-02-08

Active substances and cosmetic or dermatological preparations containing said active substances for the care of the skin of patients of diabetes mellitus

#164
20180028447
2018-02-01

Development of curcumin and piperine loaded double-layered biopolymer based nano delivery systems by using electrospray / coating method

#165
20170360982
2017-12-21

Wound Healing Composition Involving Mineral Ions and Methylglyoxal, and Methods of Use

#166
20170354637
2017-12-14

FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEA

#167
20170333515
2017-11-23

COMPOSITIONS AND METHODS FOR ENHANCING THE METABOLIC ACTIVITY OR STABILITY OF CURCUMIN

#168
20170333325
2017-11-23

Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both

#169
20170290785
2017-10-12

CURCUMIN-BASED COMPOSITIONS & METHODS OF USE THEREOF

#170
20170258743
2017-09-14

Process for preparation of bioavailable white curcumin—a unique blend of hydrogenated curcuminoids

#171
20170258742
2017-09-14

AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES

#172
20170258741
2017-09-14

Fatty acid cysteamine conjugates and their use as activators of autophagy

#173
20170196976
2017-07-13

Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof

#174
20170119694
2017-05-04

Skin cancer treatment

#175
20170112823
2017-04-27

COMPOSITIONS AND METHODS TO TREAT NEUROPATHY AND RELATED CONDITIONS

#176
20170079934
2017-03-23

Treatment for glioblastoma

#177
20170042835
2017-02-16

Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation

#178
20170029354
2017-02-02

Methods of protecting an organ using tetrahydrocurcumin and phosphatidylcholine

#179
20170027883
2017-02-02

Method for adjunctive treatment of cancer metastasis by using lycogen

#180
20160368886
2016-12-22

Multitarget hedgehog pathway inhibitors and uses thereof

#181
20160324843
2016-11-10

Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients

#182
20160317482
2016-11-03

Solid solution compositions and use in chronic inflammation

#183
20160317470
2016-11-03

Agent for inhibiting odor of pyrazine derivatives

#184
20160303060
2016-10-20

Solid solution compositions and use in chronic inflammation

#185
20160296494
2016-10-13

Dihydroorotic and acid dehydrogenase inhibitor

#186
20160296445
2016-10-13

Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both

#187
20160287533
2016-10-06

Activity Enhancing Curcumin Compositions and Methods of Use

#188
20160287531
2016-10-06

Therapeutic agents for skin diseases and conditions

#189
20160263139
2016-09-15

ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS

#190
20160243057
2016-08-25

Methods of stabilizing the extracellular matrix and compositions therefor

#191
20160220722
2016-08-04

Wound healing compositions comprising buckwheat honey and methylglyoxal and methods of use

#192
20160199398
2016-07-14

Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses

#193
20160199327
2016-07-14

Solid solution compositions and use in chronic inflammation

#194
20160175265
2016-06-23

Reactive oxygen species (ROS)-responsive compositions and methods thereof

#195
20160151305
2016-06-02

AGENT OR METHOD FOR TREATEMENT AND/OR PREVENTION OF ACCELERATED ENERGY EXPENDITURE AND/OR DIMINISHED ENERGY EXPENDITURE FUNCTIONALITY

#196
20160136275
2016-05-19

OPHTHALMIC COMPOSITION

#197
20160136070
2016-05-19

Methods and compositions for enhancing skin pigmentation

#198
20160128939
2016-05-12

Curcumin solubilisate

#199
20160114002
2016-04-28

COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA

#200
20160089443
2016-03-31

PROTEIN-GRAPHENE NANOCOMPOSITE DRUG CARRIER

#201
20160089345
2016-03-31

KIT OF OPHTHALMIC COMPOSITION

#202
20160074339
2016-03-17

Methods and compositions for preventing and treating electrophile-mediated toxicities

#203
20160030366
2016-02-04

Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer

#204
20160022573
2016-01-28

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

#205
20150366847
2015-12-24

COMBINATION OF GERANYLGERANYLACETONE AND IBUDILAST AND METHODS OF USING SAME

#206
20150343001
2015-12-03

Honey and silver nitrate composition, composition dressing and methods of making same

#207
20150342881
2015-12-03

Curcumin solubilisate

#208
20150290144
2015-10-15

Dermatitis treatment

#209
20150265575
2015-09-24

Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)

#210
20150258041
2015-09-17

TREATING OSTEOPENIA AND RELATED DISORDERS WITH GERANYLGERANYL ACETONE AND DERIVATIVES THEREOF

#211
20150202165
2015-07-23

Use of polyunsaturated ketones for the treatment of psoriasis

#212
20150148389
2015-05-28

Methods for treating or preventing brain infections

#213
20150079111
2015-03-19

MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE

#214
20150051294
2015-02-19

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#215
20150037398
2015-02-05

Molecule mixture comprising an amphipathic molecule type A, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type B and A polyphenol C, method for producing said molecule mixture and use thereof

#216
20150025154
2015-01-22

OPHTHALMIC COMPOSITION

#217
20150025049
2015-01-22

Compositions comprising exemestane and novel methods of use

#218
20150011494
2015-01-08

Therapeutic curcumin derivatives

#219
20140350119
2014-11-27

OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE

#220
20140343480
2014-11-20

SYSTEMS, METHODS, AND COMPOSITIONS FOR CROSS-LINKING

#221
20140336267
2014-11-13

UTILIZATION OF THE FUNCTION OF RARE SUGAR AS PROMOTER FOR THE MIGRATION OF GLUCOKINASE FROM NUCLEUS TO CYTOPLASM

#222
20140275283
2014-09-18

Product and method for improving bioavailability of therapeutic compounds

#223
20140275282
2014-09-18

Treating osteopenia and related disorders with geranylgeranyl acetone and derivatives thereof

#224
20140275281
2014-09-18

Geranylgeranyl acetone and derivatives thereof for intranasal administration

#225
20140275280
2014-09-18

Therapeutic uses of geranylgeranyl acetone and derivatives thereof

#226
20140256824
2014-09-11

Compositions and methods for the treatment of glomerulonephritis

#227
20140243420
2014-08-28

Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids

#228
20140243419
2014-08-28

MUCOSALLY-APPLIED AGENT FOR PREVENTION, AMELIORATION OR TREATMENT OF RETINAL DISEASE

#229
20140221426
2014-08-07

Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactivities

#230
20140219967
2014-08-07

Poly (3-Hydroxybutyrate/3-Hydroxyvalerate) of Lowered Crystallinity for Use in Animal Feed

#231
20140194528
2014-07-10

USAGE OF SODIUM HOUTTUYFONATE ON INHIBITING IDIOPATHIC PULMONARY FIBROSIS AND BLEOMYCIN INDUCED PULMONARY FIBROSIS

#232
20140194527
2014-07-10

GERANYLGERANYLACETONE FORMULATIONS AND RETINAL DELIVERY THEREOF

#233
20140187646
2014-07-03

Geranylgeranylacetone formulations and retinal and systemic delivery thereof

#234
20140171516
2014-06-19

GERANYLGERANYLACETONE FORMULATIONS

#235
20140162988
2014-06-12

Solid solution compositions and use in chronic inflammation

#236
20140162987
2014-06-12

Solid Solution Compositions and Use in Severe Pain

#237
20140161844
2014-06-12

Crosslinker enhanced repair of connective tissues

#238
20140148408
2014-05-29

Antimicrobial Compositions

#239
20140128475
2014-05-08

Agent for the prevention, improvement or treatment of retinal disease

#240
20140128353
2014-05-08

Solid Solution Compositions and Use in Cardiovascular Disease

#241
20140107219
2014-04-17

LOCAL ANAESTHETIC

#242
20140105908
2014-04-17

Methods for treating prostate cancer

#243
20140088052
2014-03-27

CHALCONE DERIVATIVES AS NRF2 ACTIVATORS

#244
20140072654
2014-03-13

CANCER WITH METABOLIC THERAPY AND HYPERBARIC OXYGEN

#245
20140045948
2014-02-13

KIT OF OPHTHALMIC COMPOSITION

#246
20130331458
2013-12-12

KIT OF OPHTHALMIC COMPOSITION

#247
20130324613
2013-12-05

Use of polyunsaturated ketones for the treatment of psoriasis

#248
20130303625
2013-11-14

AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE

#249
20130303624
2013-11-14

OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE

#250
20130303466
2013-11-14

Chemosensory Receptor Ligand-Based Therapies

#251
20130273138
2013-10-17

TRANSDERMAL FORMULATIONS OF GERANYLGERANYLACETONE

#252
20130245127
2013-09-19

Rheumatoid arthritis treatment

#253
20130245126
2013-09-19

GERANYLGERANYLACETONE FORMULATIONS AND RETINAL DELIVERY THEREOF

#254
20130225689
2013-08-29

Pharmaceutical compositions of curcumin

#255
20130203844
2013-08-08

Method for Stimulating the Reproductive Capacity in a Bull, and Composition for Stimulating the Reproductive Capacity in a Bull

#256
20130171215
2013-07-04

Process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing

#257
20130116337
2013-05-09

Methods and compositions for treating conditions mediated by oxidative stress or electrophilic environmental toxins

#258
20130090300
2013-04-11

Inhibitors of influenza endonuclease activity and tools for their discovery

#259
20130029905
2013-01-31

Formulation containing curcuminoids exhibiting enhanced bioavailability

#260
20120237566
2012-09-20

INHIBITING STOMACH-ACID RELEASE, REDUCING INFLAMMATION AND PREVENTING AND TREATING CANCER: COMPOSITIONS AND METHODS OF USE

#261
20120231079
2012-09-13

Methods and compositions for controlled delivery of phytochemical agents

#262
20120213766
2012-08-23

Anticancer Compounds from Vernonia Guineensis

#263
20120189721
2012-07-26

Methods and compositions for heavy metal detoxification

#264
20120183521
2012-07-19

Equine nutritional supplement

#265
20120177749
2012-07-12

Family of PFKFB3 inhibitors with anti-neoplastic activities

#266
20120172453
2012-07-05

METHODS FOR TREATING NEURODEGENERATIVE DISEASES

#267
20120164249
2012-06-28

Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof

#268
20120157547
2012-06-21

COMPOSITIONS AND APPLICATIONS OF CAROTENOIDS OF IMPROVED ABSORPTION AND BIOAVAILABILITY

#269
20120157465
2012-06-21

DNA methylation inhibitors

#270
20120136066
2012-05-31

Glomerulonephritis Treatment

#271
20120088840
2012-04-12

Use of panduratin derivative or extract

#272
20120082703
2012-04-05

Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals

#273
20120029071
2012-02-02

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION INJURY

#274
20120027707
2012-02-02

Lycogen extract, composition thereof and method for the treatment using the same

#275
20120009125
2012-01-12

APOE4 AND APOJ BIOMARKER-BASED PREVENTION AND TREATMENT OF DEMENTIA

#276
20120003288
2012-01-05

DISPERSION COMPOSITION AND METHOD FOR MANUFACTURING DISPERSION COMPOSITION

#277
20110280976
2011-11-17

Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

#278
20110263644
2011-10-27

Compounds and methods for treatment of stroke

#279
20110263528
2011-10-27

Antimicrobial compositions

#280
20110257255
2011-10-20

Composition and method for inhibition of nerve transmission

#281
20110230564
2011-09-22

ANT4 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

#282
20110217244
2011-09-08

Compositions and methods for enhancing immune response

#283
20110144191
2011-06-16

Compositions comprising terpene compounds for treating negative sensory phenomena

#284
20110118327
2011-05-19

In vivo assessment of toxicity and pharmacokinetics of methylglyoxal

#285
20110098333
2011-04-28

Methods for treating or preventing brain infections

#286
20100331280
2010-12-30

Modulation of the Phospholipase A2 Pathway as a Therapeutic

#287
20100316734
2010-12-16

METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT

#288
20100311843
2010-12-09

Compositions and methods for the treatment of glomerulonephritis

#289
20100305214
2010-12-02

Use of a Monoterpene to Increase Tissue Repair

#290
20100305152
2010-12-02

Method of inhibiting the growth of

#291
20100279987
2010-11-04

COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF

#292
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#293
20100204261
2010-08-12

Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers

#294
20100160365
2010-06-24

Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin

#295
20100152293
2010-06-17

Use of polyunsaturated ketones for the treatment of psoriasis

#296
20100137595
2010-06-03

VAGINAL ODORANTS

#297
20100130435
2010-05-27

UTILIZATION OF THE FUNCTION OF RARE SUGAR AS PROMOTER FOR THE MIGRATION OF GLUCOKINASE FROM NUCLEUS TO CYTOPLASM

#298
20100093985
2010-04-15

USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS

#299
20100093870
2010-04-15

HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS

#300
20100068141
2010-03-18

USE OF HEAT SHOCK TO TREAT OCULAR DISEASE